---
figid: PMC3959597__zee9991474350007
figtitle: Cross talk between metformin, androgens, and IGF system and molecular mechanisms
  of metformin inhibitory effects
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3959597
filename: zee9991474350007.jpg
figlink: /pmc/articles/PMC3959597/figure/F7/
number: F7
caption: 'Cross talk between metformin, androgens, and IGF system and molecular mechanisms
  of metformin inhibitory effects. In prostate cancer cells, androgens up-regulate
  IGF-IR by inducing CREB transcriptional activation through membrane-initiated activation
  of the Src/MAPK/phosphoinositide 3-kinase (PI3K) pathway. The molecular mechanisms
  by which metformin may disrupt this androgen effect include: 1) inhibition of androgen-induced
  TORC2 dephosphorylation and nuclear translocation with consequent reduction in CREB/TORC2
  complex transcription activity; 2) inhibition of mTOR/p70S6K signaling, partially
  through the AMPK and REDD1 pathways; and 3) Disruption of AR/c-Src interaction and
  inhibition of AR phosphorylation. Ras, rat sarcoma; Raf, rapidly accelerated fibrosarcoma;
  Mek, mitogen-activated protein kinase kinase.'
papertitle: Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer
  Cells by Disrupting Membrane-Initiated Androgen Signaling.
reftext: Roberta Malaguarnera, et al. Endocrinology. 2014 Apr;155(4):1207-1221.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9665773
figid_alias: PMC3959597__F7
figtype: Figure
redirect_from: /figures/PMC3959597__F7
ndex: b5867b03-dece-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3959597__zee9991474350007.html
  '@type': Dataset
  description: 'Cross talk between metformin, androgens, and IGF system and molecular
    mechanisms of metformin inhibitory effects. In prostate cancer cells, androgens
    up-regulate IGF-IR by inducing CREB transcriptional activation through membrane-initiated
    activation of the Src/MAPK/phosphoinositide 3-kinase (PI3K) pathway. The molecular
    mechanisms by which metformin may disrupt this androgen effect include: 1) inhibition
    of androgen-induced TORC2 dephosphorylation and nuclear translocation with consequent
    reduction in CREB/TORC2 complex transcription activity; 2) inhibition of mTOR/p70S6K
    signaling, partially through the AMPK and REDD1 pathways; and 3) Disruption of
    AR/c-Src interaction and inhibition of AR phosphorylation. Ras, rat sarcoma; Raf,
    rapidly accelerated fibrosarcoma; Mek, mitogen-activated protein kinase kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Src42A
  - Csk
  - Src64B
  - ar
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Raf
  - SNF4Agamma
  - AMPKalpha
  - Dsor1
  - Mtk
  - Mtor
  - Tor
  - S6k
  - Erk7
  - rl
  - Crtc
  - CrebB
  - CrebA
  - IGF1R
  - SRC
  - FGR
  - FYN
  - YES1
  - AR
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - DDIT4
  - RPS6KB1
  - RPS6KB2
  - EPHB2
  - MAPK1
  - MAPK3
  - CRTC2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
